Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine.

Autor: Nobrega FL; CEB - Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal., Costa AR; CEB - Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal., Santos JF; CEB - Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal., Siliakus MF; Laboratory of Microbiology, Wageningen University and Research Centre, Stippeneng 4, 6708 WE Wageningen, The Netherlands., van Lent JW; Laboratory of Virology, Department of Plant Sciences, Wageningen University, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands., Kengen SW; Laboratory of Microbiology, Wageningen University and Research Centre, Stippeneng 4, 6708 WE Wageningen, The Netherlands., Azeredo J; CEB - Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal., Kluskens LD; CEB - Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2016 Dec 15; Vol. 6, pp. 39235. Date of Electronic Publication: 2016 Dec 15.
DOI: 10.1038/srep39235
Abstrakt: Orally administered phages to control zoonotic pathogens face important challenges, mainly related to the hostile conditions found in the gastrointestinal tract (GIT). These include temperature, salinity and primarily pH, which is exceptionally low in certain compartments. Phage survival under these conditions can be jeopardized and undermine treatment. Strategies like encapsulation have been attempted with relative success, but are typically complex and require several optimization steps. Here we report a simple and efficient alternative, consisting in the genetic engineering of phages to display lipids on their surfaces. Escherichia coli phage T7 was used as a model and the E. coli PhoE signal peptide was genetically fused to its major capsid protein (10 A), enabling phospholipid attachment to the phage capsid. The presence of phospholipids on the mutant phages was confirmed by High Performance Thin Layer Chromatography, Dynamic Light Scattering and phospholipase assays. The stability of phages was analysed in simulated GIT conditions, demonstrating improved stability of the mutant phages with survival rates 10 2 -10 7 pfu.mL -1 higher than wild-type phages. Our work demonstrates that phage engineering can be a good strategy to improve phage tolerance to GIT conditions, having promising application for oral administration in veterinary medicine.
Databáze: MEDLINE